Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

I say have a little faith in Bril! Get the phase II ready using the grant for mild to moderate CV19 patients. This should raise our valuation substantially between 250m to $300m+. I personally would not wait for the government to fund or give us another grant to do another clinical trial. We got to strike while the iron is hot, Leo!

Then follow that up with a private placement funding to do fund another subset of PII that targets severe and critically ill patients. This round of funding could easily push our valuation close to $1b, Leo. The round of financing should be enough to expand the team and get us uplisted to NASDAQ.